Guideline on good pharmacovigilance practices (GVP) Product- or Population-Specific Considerations II: Pregnant and breastfeeding women

Guideline on good pharmacovigilance practices (GVP) Product- or Population-Specific Considerations II: Pregnant and breastfeeding women

2024-09-01
Guideline on good pharmacovigilance practices (GVP) Product- or Population-Specific Considerations II: Pregnant and breastfeeding women
Guide
Drugs
Has the page content helped you?